GSK (NYSE:GSK) shares snapped six straight sessions of gains, as the stock ended down 0.6% at $38.70 on Friday.

The pharmaceutical giant added 3.6% in the preceding six sessions. The stock has gained over 14% so far this year, compared to a 0.7% drop in the